Technological watch

Thermo Fisher investing $180M to meet diagnostics, bioprocessing demands

Thermo Fisher Scientific Inc. is building two new manufacturing facilities and expanding capacity at an existing site to keep up with demand for diagnostics and bioprocessing products.

Pipette tip demand continues to increase, as COVID-19 testing continues and non-COVID demand rapidly increased through the end of 2020, Sung-Dae Hong, vice president and general manager of laboratory plastics essentials at Thermo Fisher, told Plastics News.

"We continue to see increasing demand for pipette tips intended for diagnostic use," Hong said. "With the impact of the delta variant and increased testing, we are seeing demand rise again. … We have been in a supply constraint situation for more than a year."

The Waltham, Mass.-based company has invested $180 million to build up its team, facilities and capabilities to meet that demand, she said.

"Overall demand for consumables is still at a record high," Hong said. "To meet that demand, we have been investing in capacity for a number of different product lines in our plastics portfolio, including pipette tips, since early last year."

Publication date: 17/09/2021

Plastics News


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 870292.